The presence of pulmonary hypertension affects lung transplantation in multiple ways, from patient selection, transplant risks, type of transplant, intraoperative management, to transplant outcome. A working knowledge of natural disease progression, the latest medical treatment options, and transplant outcome is critical in patient selection, and a good understanding of the transplant process, including the new transplant allocation system, is important for physicians involved in the care of patients with pulmonary arterial hypertension. The complexity of these factors underscores the importance of good communication between referring physicians and transplant centers.
United Network for Organ Sharing. Available at: http:// www.unos.org.
2.
Kaiser LR, Pasque MK, Trulock EP, et al. Bilateral sequential lung transplantation: the procedure of choice for double-lung replacement. Ann Thorac Surg.1991; 52:438-445.
3.
2005 OPTN/SRTR annual report. Available at: http:// www.ustransplant.org.
4.
Conte JV, Gaine SP, Orens JB, et al. The influence of continuous intravenous prostacyclin on the timing and outcome of transplantation for primary pulmonary hypertension. J Heart Lung Transplant.1998;17:679-685.
5.
Yung GL, Kriett JM, Jamieson SW, et al. Outpatient inhaled nitric oxide in a patient with idiopathic pulmonary fibrosis: a bridge to lung transplantation. J Heart Lung Transplant.2001;20:1224-1227.
6.
Maurer JR, Frost AE, Estenne M., et al. International guidelines for the selection of lung transplant candidates. Transplantation. 1998;66:951-956.
7.
Arcasoy SM, Kotloff RMLung transplantation. N Engl J Med.1999;340:1081-1091.
8.
Smith CMPatient selection, evaluation, and preoperative management for lung transplant candidates. Clin Chest Med.1997;18:183-197.
9.
Kuo PC, Stock PGTransplantation in the HIV+ patient. Am J Transplant. 2001;1:13-17.
10.
Roland MESolid-organ transplantation in HIV-infected patients in the potent antiretroviral therapy era. Top HIVMed.2004;12:73-76.
11.
Fitton TP, Kosowski TR, Barreiro CJ, et al. Impact of secondary pulmonary hypertension on lung transplant outcome. J Heart Lung Transplant.2005;24:1254-1259.
12.
Whelan TP, Dunitz JM, Kelly RF, et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant.2005;24:1269-1274.
13.
Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report, 2005. J Heart Lung Transplant.2005;24:956-967.
14.
McLaughlin VV, Gaine SP, Barst RJ, et al. Survival in primary pulmonary hypertension: the impact of Epoprostenol therapy. Circulation. 2002;106:1477-1482.
15.
Galie N., Ghofrani HA, Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension . N Eng J Med.2005;353:2148-2157.
16.
Kim H., Yung GL, Marsh JJ, et al. Endothelin mediates pulmonary vascular remodeling in a canine model of chronic embolic pulmonary hypertension. Eur Resp J. 2000;15:640-648.
17.
Kim H., Yung GL, Marsh JJ, et al. Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase . Exp Lung Res. 2000;26:287-301.
18.
Provencher S., Sitbon O., Humbert M., et al. Long-term outcome with first-line Bosentan therapy in idiopathic pulmonary arterial hypertension. Eur Heart J.2006; 27:589-595.
19.
Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Eng J Med.1982;306:557-564.
20.
Chapelier A. , Vouhe P., Macchiarini P., et al. Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg.1993; 106:229-307.
21.
Whyte RI, Robbins RC, Altinger J., et al. Heart-lung transplantation for primary pulmonary hypertension . Ann Thorac Surg.1999 ;67:937-941.
22.
Franke K., Wiebe K., Harringer W., et al. Ten years experience with lung and heart-lung transplantation in primary and secondary pulmonary hypertension. Eur J Cardiothorac Surg.2000;18:447-452.
23.
Ritchie M., Waggoner AD, Davila-Roman VG, et al. Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single lung transplantation. J Am Coll Cardiol.1993;22:1170-1174.
24.
Boujoukos AJ , Martich GD, Vega JD, et al. Reperfusion injury in single lung transplant recipients with pulmonary hypertension and emphysema. J Heart Lung Transplant.1997; 16:440-448.
25.
Bando K., Armitage JM, Paradis IL, et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovac Surg.1994;108:1056-1065.
26.
Pasque MK, Trulock EP, Cooper JD, et al. Single lung transplantation for pulmonary hypertension: single institution experience in 34 patients. Circulation. 1995;92: 2252-2258.
27.
Gammie JS, Keenan RJ, Pham SM, et al. Single versus double lung transplantation for pulmonary hypertension . J Thorac Cardiovasc Surg.1998;115:397-402.
28.
Conte JV, Borja MJ, Patel CB, et al. Lung transplantation for primary and secondary pulmonary hypertension . Ann Thorac Surg.2001;72:1673-1680.
29.
Cooper JD, Patterson GA, Trulock EPResults of single and bilateral lung transplantation in 131 consecutive recipients. Washington University Lung Transplant Group. J Thorac Cardiovasc Surg.1994;107:460-470.
30.
Ueno T., Smith JA, Snell GI, et al. Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger's syndrome. Ann Thorac Surg.2000;2: 381-387.
31.
Mendeloff EN , Meyers BF, Sundt TM, et al. Lung transplantation for pulmonary vascular disease. Ann Thorac Surg.2002;73:209-219.
32.
McCurry KR, Keenan RJControlling perioperative morbidity and mortality after lung transplantation for pulmonary hypertension. Semin Thorac Cardiovasc Surg.1998;10:139-143.
33.
Badesch DB, Zamora MR, Jones S., et al. Independent ventilation and ECMO for severe unilateral pulmonary edema after SLT for primary pulmonary hypertension. Chest.1995;107:1766-1770.
34.
Meyers BF, Sundt TM, Henry S., et al. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg.2000; 120: 20-26.
35.
Pereszlenyi A. , Lang G., Steltzer H., et al. Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension. Eur J Cardiothorac Surg.2002 ;21:858-863.
36.
Snell GI, Salamonsen RF, Bergin P., Esmore DS, Khan S., Williams TJInhaled nitric oxide as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med.1995; 151:1263-1266.
37.
Pinsky DJ, Naka Y., Chowdhurry NC, et al. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci U S A.1994;91:12086-12090.
38.
Liu M., Tremblay L., Cassivi SD, et al. Alterations of nitric oxide synthase expression and activity during rat lung transplantation. Am J Physiol Lung Cell Mol Physiol. 2000;278:L1071-L1081.
39.
Meade MO, Granton JT, Matte-Martyn A., et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med.2003;167:1483-1489.
40.
Date H., Triantafillou AN, Trulock EP, et al. Inhaled nitric oxide reduces human lung allograft dysfunction . J Thorac Cardiovasc Surg.1996;111:913-919.
41.
Cornfield DV , Milla DE, Haddad IY, et al. Safety of inhaled nitric oxide after lung transplantation. J Heart Lung Transplant.2003;22:903-907.
